STOCK TITAN
  1. Home
  2. News
  3. PETVW

PETVIVO HOLDINGS INC WTS - PETVW STOCK NEWS

Welcome to our dedicated page for PETVIVO HOLDINGS WTS news (Ticker: PETVW), a resource for investors and traders seeking the latest updates and insights on PETVIVO HOLDINGS WTS stock.

PETVIVO HOLDINGS INC WTS (symbol: PETVW) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. With a strategic approach of leveraging investments in human biomaterials and medical device industries, PETVIVO aims to bring therapeutics to pets in a capital and time-efficient manner. The company's core strategy involves in-licensing proprietary products from human medical device companies for pet use. PETVIVO HOLDINGS INC WTS is the parent company of petvivo, inc, gel-del technologies, inc, and cosmetalife corporation.

News

PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales

Rhea-AI Summary

PetVivo Holdings has appointed Bryan Monninger as their new VP of Sales. Monninger brings over 20 years of experience in sales and marketing, including senior roles at NOVUS, Colgate-Palmolive, Lintbells, and ConAgra. He will lead PetVivo's sales and distribution teams to expand the market adoption of their animal osteoarthritis product, Spryng™ with OsteoCushion™ Technology. Monninger's extensive background includes successful market entries, strategic planning, and sales growth acceleration. CEO John Lai expects Monninger's expertise to drive PetVivo's growth and expand their market reach both domestically and internationally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News

April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing

Rhea-AI Summary

PetVivo Holdings announced that April Boyce has joined as Vice President of Marketing. Boyce, with over 20 years of experience in consumer-packaged goods (CPG) marketing, sales, and strategic partnerships, has held significant roles at Procter & Gamble and Clorox. At Clorox, she led the shopper marketing division and formed strategic partnerships with companies like Burt's Bees, Coca-Cola, and Tyson Foods. Her most recent role was Chief Commercial Officer at pet tech start-up, Link. Boyce aims to enhance awareness and understanding of PetVivo's veterinary medical device, Spryng with OsteoCushion Technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA

Rhea-AI Summary
PetVivo Holdings, Inc. will be a Silver Sponsor at the IVAPM Pain Management Forum to exhibit its lead product, Spryng™ with OsteoCushion™ Technology. The clinical studies on Spryng show significant improvements in dogs with joint diseases, making it a promising veterinary medical device for osteoarthritis management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA

Rhea-AI Summary
PetVivo Holdings, Inc. will showcase its innovative veterinary medical device, Spryng, with OsteoCushion Technology at the ACVSMR Symposium. Spryng aims to manage joint pain in pets by promoting proper joint mechanics. CEO John Lai expresses excitement for the opportunity to present Spryng at the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA

Rhea-AI Summary
PetVivo Holdings, Inc. announces its participation in the ACVSMR Symposium to showcase its lead product, SPRYNG™ with OsteoCushion™ Technology, aimed at managing joint pain in pets. The event will be held from April 11th to April 13th, 2024, in Naples, Florida.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer

Rhea-AI Summary
PetVivo Holdings, Inc. appoints Garry Lowenthal as the new Chief Financial Officer, bringing over 25 years of extensive experience in finance management and operations. Mr. Lowenthal's background includes leading equity capital raising transactions for private and public companies, serving on the national board of Financial Executives International, and working for top CPA/Consulting firms like PricewaterhouseCoopers and Deloitte.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV

Rhea-AI Summary
PetVivo Holdings, Inc. dual lists on Upstream's global securities trading app, providing digital-first investors worldwide with streamlined access to PETV shares. The company's free NFT commemorating the listing is available for all Upstream participants. Non-U.S. investors can deposit or trade PETV securities on Upstream, with trading starting after the first offer is placed. The market operates 5 days a week, 20 hours a day, offering real-time trading and settlement with transparent orderbooks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California

Rhea-AI Summary
PetVivo Holdings, Inc. announced the successful completion of the first cohort of dogs in a clinical study focusing on the benefits of an intra-articular injection of collagen-elastin hydrogel microparticles for dogs with osteoarthritis. The study showed promising results with significant improvements in CBPI scores, hip extension, visual lameness scores, and quality of life assessments. Spryng™ with OsteoCushion™ Technology appears to be a viable option for managing coxofemoral joint osteoarthritis in companion animals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
clinical trial
-
News

PetVivo Holdings, Inc. Approved to Dual List on Upstream

Rhea-AI Summary
PetVivo Holdings, Inc. (PETV) to dual list shares on Upstream for global trading starting March 5, 2024. Shareholders to receive commemorative NFT. Upstream offers real-time trading, transparent orderbook, and digital collectibles for participants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA

Rhea-AI Summary
PetVivo Holdings, Inc. will showcase its innovative veterinary medical device, SPRYNG™ with OsteoCushion™ Technology, at the Western Veterinary Conference. The conference, hosting over 15,000 participants, offers a platform for PetVivo to engage with industry professionals and promote its joint pain management solution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of PETVIVO HOLDINGS WTS (PETVW)?

The current stock price of PETVIVO HOLDINGS WTS (PETVW) is $0.026 as of February 3, 2025.

What does PETVIVO HOLDINGS INC WTS specialize in?

PETVIVO focuses on licensing and commercializing innovative medical devices for pets, also known as pet therapeutics.

What is PETVIVO's strategic approach?

The company leverages investments in human biomaterials and medical device industries to efficiently bring therapeutics to pets.

How does PETVIVO commercialize products for pets?

PETVIVO in-licenses proprietary products from human medical device companies specifically for pet use.

What subsidiaries are under PETVIVO HOLDINGS INC?

petvivo, inc, gel-del technologies, inc, and cosmetalife are all wholly-owned subsidiaries of PETVIVO HOLDINGS INC.

What is PETVIVO's core business model?

PETVIVO's core model involves commercializing innovative medical devices for pets through strategic partnerships.

What is the significance of PETVIVO in the biomedical device industry?

PETVIVO plays a crucial role by bringing human medical advancements to the pet therapeutics sector.

How does PETVIVO ensure efficient commercialization of pet therapeutics?

PETVIVO's strategy focuses on in-licensing products from human medical device companies, streamlining the process.

What sets PETVIVO apart in the pet therapeutics market?

PETVIVO's unique approach of leveraging human medical device technology for pets sets it apart in the industry.

What are some recent achievements of PETVIVO HOLDINGS INC WTS?

PETVIVO has successfully partnered with leading human medical device companies to bring cutting-edge therapeutics to pets.

What can investors expect from PETVIVO's future projects?

Investors can anticipate further advancements in pet therapeutics through PETVIVO's ongoing projects and collaborations.
Stock PETVW logo
PETVIVO HOLDINGS INC WTS

OTC:PETVW

PETVW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

PETVW Stock Data

Medical Devices
Healthcare
Link
United States of America
Edina